Clinical Experience with Gene Therapy and Bispecific Antibodies for T Cell-based Therapy of Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1399-1408

Bentham Science Publishers

Access to resources Recommend Favorite

Bispecific antibodies for the treatment of tumours and infectious diseases

By Drakeman D.L.   Fanger M.W.   Wallace P.K.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1169-1178

Informa Healthcare

Access to resources Recommend Favorite

Generation of Bispecific Antibodies by Fc Heterodimerization and their Application

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1324-1332

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies as Innovative Therapeutics

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. : 423-430

Bentham Science Publishers

Access to resources Recommend Favorite

Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo

By English Diana P.   Bellone Stefania   Schwab Carlton L.   Roque Dana M.   Lopez Salvatore   Bortolomai Ileana   Cocco Emiliano   Bonazzoli Elena   Chatterjee Sudeshna   Ratner Elena   Silasi Dan-Arin   Azodi Masoud   Schwartz Peter E.   Rutherford Thomas J.   Santin Alessandro D.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 403-412

Blackwell Publishing

Access to resources Recommend Favorite